Literature DB >> 32241434

Cordyceps sinensis polysaccharide inhibits colon cancer cells growth by inducing apoptosis and autophagy flux blockage via mTOR signaling.

Wucheng Qi1, Xingtao Zhou2, Junqiao Wang1, Ke Zhang1, Yujia Zhou1, Shuping Chen1, Shaoping Nie1, Mingyong Xie3.   

Abstract

Cordyceps sinensis is thought to have anti-cancer effects, but its mechanisms remain elusive. In this study, we aimed to investigate the anti-cancer effect of Cordyceps sinensis polysaccharide (CSP) on human colon cancer cell line (HCT116) and its mechanism. Results indicated that CSP significantly inhibited the proliferation of HCT116 cells, increased autophagy and apoptosis, while blocked autophagy flux and lysosome formation. Further experiments showed that CSP decreased the expression of PI3K and phosphorylation level of AKT and mTOR, increased the expression of AMPKa and phosphorylation level of ULK1. In addition, repression of CSP-induced autophagy by bafilomycin (autophagy inhibitor) enhanced apoptosis and cell death of HCT116 cells. Hence, our findings suggested that CSP inhibited the proliferation of HCT116 cells by inducing apoptosis and autophagy flux blockage, which might be achieved through PI3K-AKT-mTOR and AMPK-mTOR-ULK1 signaling. CSP may be a potential therapeutic agent for colon cancer.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-Methyladenine (PubChem CID: 135398661); Apoptosis; Autophagy; Bafilomycin A1 (PubChem CID: 6436223); Colon cancer cell; Cordyceps sinensis polysaccharide; Rapamycin (PubChem CID: 5284616); mTOR signaling

Year:  2020        PMID: 32241434     DOI: 10.1016/j.carbpol.2020.116113

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  14 in total

Review 1.  How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?

Authors:  Yulia Kirdeeva; Olga Fedorova; Alexandra Daks; Nikolai Barlev; Oleg Shuvalov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

2.  Activities of the soluble and non-digestible longan (Dimocarpus longan Lour.) polysaccharides against HCT-116 cells as affected by a chemical selenylation.

Authors:  Ya-Hui Yu; Li Wang; Qiang Zhang; Xiao-Nan Zhang; Xin-Huai Zhao
Journal:  Curr Res Food Sci       Date:  2022-06-24

3.  Astragalus Shiitake-A Novel Functional Food with High Polysaccharide Content and Anti-Proliferative Activity in a Colorectal Carcinoma Cell Line.

Authors:  Bunu Tamang; Qi Liang; Biju Balakrishnan; Su Peng; Wei Zhang
Journal:  Nutrients       Date:  2022-06-02       Impact factor: 6.706

4.  Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation.

Authors:  Yuhong Jiang; Xin Zhuo; Xiujuan Fu; Yue Wu; Canquan Mao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

5.  Therapeutic Potential of Selenium and Selenium Compounds in Cervical Cancer.

Authors:  Ewa Jablonska; Qi Li; Edyta Reszka; Edyta Wieczorek; Kateryna Tarhonska; Tong Wang
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

Review 6.  Mycomedicine: A Unique Class of Natural Products with Potent Anti-tumour Bioactivities.

Authors:  Rongchen Dai; Mengfan Liu; Wan Najbah Nik Nabil; Zhichao Xi; Hongxi Xu
Journal:  Molecules       Date:  2021-02-19       Impact factor: 4.411

Review 7.  Polysaccharides as Potential Anti-tumor Biomacromolecules -A Review.

Authors:  Rui Guo; Min Chen; Yangyang Ding; Pengyao Yang; Mengjiao Wang; Haihui Zhang; Yuanqing He; Haile Ma
Journal:  Front Nutr       Date:  2022-02-28

8.  Effects of Different Molecular Weight Polysaccharides From Dendrobium officinale Kimura & Migo on Human Colorectal Cancer and Transcriptome Analysis of Differentially Expressed Genes.

Authors:  Shengchang Tao; Zhiyao Ren; Zerui Yang; Shuna Duan; Zhongxian Wan; Jiahui Huang; Chenxing Liu; Gang Wei
Journal:  Front Pharmacol       Date:  2021-12-03       Impact factor: 5.810

Review 9.  Macrofungi as a Nutraceutical Source: Promising Bioactive Compounds and Market Value.

Authors:  Allen Grace Niego; Sylvie Rapior; Naritsada Thongklang; Olivier Raspé; Wuttichai Jaidee; Saisamorn Lumyong; Kevin D Hyde
Journal:  J Fungi (Basel)       Date:  2021-05-19

10.  GRP78 determines glioblastoma sensitivity to UBA1 inhibition-induced UPR signaling and cell death.

Authors:  Guanzheng Liu; Jiefeng Yu; Runqiu Wu; Lin Shi; Xu Zhang; Wanhong Zhang; Xiaomin Zhong; Yifeng Wang; Huan Li; Yang Shen; Changyong Wu; Rutong Yu; Mingshan Niu; Xuejiao Liu
Journal:  Cell Death Dis       Date:  2021-07-23       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.